SCHEMBL18159954

SCHEMBL18159954

CCCCCC(N)C(=O)NC(CCCCNC(=O)C(N)CCCCN)C(=O)NCCCCC(NC(=O)C(N)CCCCNC(=O)C(N)CCCCN)C(C)=O

nearest known ligand 0.71

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ GNAI3 P08754 1/20 0.71
▸ GNAO1 P09471 1/20 0.71
▸ GNAI1 P63096 1/20 0.71
▸ SIRT1 Q96EB6 2/20 0.69
▸ SIRT6 Q8N6T7 1/20 0.69
▸ DPP7 Q9UHL4 4/20 0.60
▸ RRM1 P23921 1/20 0.59
▸ TLR2 O60603 6/20 0.52
▸ NOD1 Q9Y239 1/20 0.51
▸ DPP8 Q6V1X1 2/20 0.50
▸ DPP9 Q86TI2 2/20 0.50
▸ DPP4 P27487 1/20 0.45
▸ SIRT2 Q8IXJ6 1/20 0.45
▸ SIRT3 Q9NTG7 1/20 0.45
▸ NMT2 O60551 2/20 0.43
▸ NMT1 P30419 2/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18159955 0.99 GNAI3 (0.70) GNAI3GNAO1GNAI1SIRT1SIRT6
SCHEMBL18653407 0.94 GNAI3 (0.60) GNAI3GNAO1GNAI1SIRT1SIRT6
SCHEMBL13318345 0.94 GNAI3 (0.60) GNAI3GNAO1GNAI1SIRT1SIRT6
SCHEMBL22991807 0.93 GNAI3 (0.80) GNAI3GNAO1GNAI1SIRT1SIRT6
SCHEMBL13318350 0.92 GNAI3 (0.62) GNAI3GNAO1GNAI1SIRT1SIRT6
SCHEMBL13318347 0.92 SIRT6 (0.60) GNAI3GNAO1GNAI1SIRT1SIRT6
SCHEMBL18672578 0.92 GNAI3 (0.61) GNAI3GNAO1GNAI1SIRT1SIRT6
SCHEMBL13318346 0.92 GNAI3 (0.65) GNAI3GNAO1GNAI1SIRT1SIRT6
SCHEMBL13318352 0.92 GNAI3 (0.65) GNAI3GNAO1GNAI1SIRT1SIRT6
SCHEMBL13318351 0.92 GNAI3 (0.65) GNAI3GNAO1GNAI1SIRT1SIRT6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9603953-B2 Dendrimer compositions, methods of synthesis, and uses thereof YANG, Guanghua (FR) 2017-03-28 — — US disclosed
US-9603953-B2 Dendrimer compositions, methods of synthesis, and uses thereof YANG, Guanghua (FR) 2017-03-28 — — US disclosed
US-20160303261-A1 DENDRIMER COMPOSITIONS, METHODS OF SYNTHESIS, AND USES THEREOF SADEG, Nouredine (FR) 2016-10-20 — — US disclosed
US-20160303261-A1 DENDRIMER COMPOSITIONS, METHODS OF SYNTHESIS, AND USES THEREOF SADEG, Nouredine (FR) 2016-10-20 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160303261-A1 DENDRIMER COMPOSITIONS, METHODS OF SYNTHESIS, AND USES THEREOF DDOST, CD44, CLTB GNAI3 871/4885GNAO1 1940/4885GNAI1 1236/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback